Showing results (121-130 of 22,005) with videos related to
Sort By:
Pageof 2,201
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Interisland and interarchipelago transfer of stone tools in prehistoric PolynesiaM I Weisler, P V KirchTherapeutic Advances in Cardiovascular Disease|January 16, 2009
Current pharmacotherapeutic concepts for the treatment of obesity in adultsEvgeny Idelevich, Wilhelm Kirch, Christoph SchindlerKlinische Wochenschrift|October 1, 1978
[Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)]H Köhler, W Kirch, H PitzMedizinische Klinik (Munich, Germany : 1983)|February 4, 2010
[Chlorambucil treatment of Behçet's syndrome. Retrospective evaluation of two cases]Andreas Eichhorn, Martin Siepmann, Wilhelm KirchJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 14, 2001
The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interactionP Laeis, K Püchler, W KirchInternational Journal of Clinical Pharmacology and Therapeutics|November 30, 2000
Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjectsU Ebert, R Oertel, W KirchProceedings of the National Academy of Sciences of the United States of America|December 15, 1990
Prehistoric extinction of birds on Mangaia, Cook Islands, PolynesiaD W Steadman, P V KirchThe American Journal of Psychiatry|June 1, 1988
Polydipsia and hyponatremia in psychiatric patientsB P Illowsky, D G KirchCurrent Medical Research and Opinion|October 7, 2004
The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary careP Bramlage, D Pittrow, W KirchJournal of Clinical Pharmacology|February 1, 1995
Clinical aspects of cardiovascular effects of H2-receptor antagonistsH Hinrichsen, A Halabi, W KirchPageof 2,201